From owner-7tms_r@net.bio.net Fri Mar 03 22:00:00 1995
Newsgroups: bionet.molbio.proteins.7tms_r
Path: biosci!agate!howland.reston.ans.net!paladin.american.edu!newsfeed.ACO.net!swidir.switch.ch!univ-lyon1.fr!ghost.dsi.unimi.it!genes!karami
From: karami@genes.icgeb.trieste.it (Ali Karami)
Subject: Mab for OspA of Borrelia????
Message-ID: <1995Mar3.181631.6123@genes.icgeb.trieste.it>
Organization: ICGEB
X-Newsreader: TIN [version 1.2 PL2]
Date: Fri, 3 Mar 1995 18:16:31 GMT
Lines: 27

From karami Fri Mar  3 18:58:51 1995
Return-Path: <karami>
Received: by icgeb.trieste.it (AA05218); Fri, 3 Mar 95 18:58:50 +0100
Date: Fri, 3 Mar 95 18:58:50 +0100
From: Ali Karami <karami>
Message-Id: <9503031758.AA05218@icgeb.trieste.it>
To: karami@icgeb.trieste.it (Ali Karami)
Subject: Re: Mab for OspA of Borrelia????
Newsgroups: bionet.immunology
Organization: ICGEB
X-Newsreader: TIN [version 1.2 PL2]
Status: OR


In article <1995Mar3.174607.5025@genes.icgeb.trieste.it> you wrote:

 I need Monoclonal Ab against OspA of Borrelia burgdorferi ?

 How can I find it ? I want to do few Immuno blotting with mY protein.
 I would appreciate Any help.

 Thank you
 Ali Karami

Ali@biobase.dk



From owner-7tms_r@net.bio.net Sat Mar 04 22:00:00 1995
Path: biosci!GIBBS.OIT.UNC.EDU!laiter
From: laiter@GIBBS.OIT.UNC.EDU (Sergei Laiter)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: models of B2 adrenoreceptors
Date: 5 Mar 1995 11:58:39 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 7
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.3.89.9503051431.A29560-0100000@gibbs.oit.unc.edu>
NNTP-Posting-Host: net.bio.net


Dear netters, 
I'm modeling G-protein coupled receptors and I'mparticularly 
interested in existing models of B2 adrenoreceptors. If anyone would 
provide me with their models of these receptors I would appreciate it.

-Sergei

From owner-7tms_r@net.bio.net Sun Mar 05 22:00:00 1995
Path: biosci!adam.cc.sunysb.edu!news.nysernet.net!news.sprintlink.net!pipex!warwick!news.dcs.warwick.ac.uk!hgmp.mrc.ac.uk!daresbury!not-for-mail
From: mcroos@imb-jena.de (Martin Roos)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Mab for OspA of Borrelia????
Date: 6 Mar 1995 09:37:00 -0000
Lines: 19
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <3jel3s$lik@mserv1.dl.ac.uk>
Original-To: 7tms_r@dl.ac.uk

Ali Karami wrote:

>I need Monoclonal Ab against OspA of Borrelia burgdorferi ?
>
> How can I find it ? I want to do few Immuno blotting with mY protein.  I
>would appreciate Any help.

You might succeed in getting a Mab by contacting either Michael Kramer
(Universitdt Heidelberg, Institut f|r Immunologie, Abteilung f|r
Immunpathologie) or Markus Simon (Freiburg, Max-Planck.Institut f|r
Immunbiologie).
In the lab of Michael Kramer I once worked as a trainee. If you will not find
out the phone numbers just contact me again.

Greetings
Martin Roos

mcroos@imb-jena.de


From owner-7tms_r@net.bio.net Tue Mar 07 22:00:00 1995
Path: biosci!NIFTYSERVE.OR.JP!JCF11024
From: JCF11024@NIFTYSERVE.OR.JP (=?ISO-2022-JP?B?GyRCNmJFRCEhPSEwbE86GyhC?=)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: HELP
Date: 8 Mar 1995 06:32:12 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199503081432.XAA10497@inetnif.niftyserve.or.jp>
NNTP-Posting-Host: net.bio.net

HELP

From owner-7tms_r@net.bio.net Tue Mar 07 22:00:00 1995
Path: biosci!bcm!cs.utexas.edu!howland.reston.ans.net!gatech!newsxfer.itd.umich.edu!news.itd.umich.edu!usenet
From: Rick Neubig <RNeubig@umich.edu>
Newsgroups: bionet.molbio.proteins.7tms_r,bionet.molbio.proteins
Subject: Ultracold storage
Date: 9 Mar 1995 00:01:21 GMT
Organization: University of Michigan
Lines: 15
Message-ID: <3jlggi$41c@lastactionhero.rs.itd.umich.edu>
NNTP-Posting-Host: pm002-24.dialip.mich.net
Xref: biosci bionet.molbio.proteins.7tms_r:199 bionet.molbio.proteins:3929

We just got a new freezer that can go to -86 C and I wondered
if anybody had personal experience with storage of G proteins
and/or 7tm receptors/membranes at different temperatures. We've
always stored them at -70. Do they remain more stable at lower
temps (e.g. -80 or -86).

My initial reaction was "put it as cold as it gets" but apparently
that leads to more problems with frosting up and more stress on
motors and compressors.

So - at what temperature do you all store your precious G proteins
and 7tms_r's and is there any rational basis for the choice?

Rick Neubig
http://www.umich.edu/~rneubig

From owner-7tms_r@net.bio.net Wed Mar 08 22:00:00 1995
Path: biosci!SMTPGATE.ICOS.COM!pgray
From: pgray@SMTPGATE.ICOS.COM
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: subscribe
Date: 9 Mar 1995 13:03:59 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9502097947.AA794783079@smtpgate.icos.com>
NNTP-Posting-Host: net.bio.net

Subscribe

From owner-7tms_r@net.bio.net Tue Mar 14 22:00:00 1995
Path: biosci!RECEPTOR.MGH.HARVARD.EDU!lfk
From: lfk@RECEPTOR.MGH.HARVARD.EDU (Lee F. (Frank) Kolakowski)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: subscribe
Date: 15 Mar 1995 09:25:19 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 28
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9503151345.AA02401@receptor>
References: <9502097947.AA794783079@smtpgate.icos.com>
NNTP-Posting-Host: net.bio.net


Dear Dr. Gray,

We do not have any informative data about your clone R2 yet. 

We did start a newsgroup and a mailing list under the BIOSCI
system. If you are able to read any of the electronic newsgroups
bionet.*, then just ask the administrator of that system to add the
bionet.molbio.proteins.7tms_r newsgroup.

If you are unable to read news and want to get it by email
send a message to biosci-server@net.bio.net
in the message say 'subscribe 7tms_r'

Then all email to 7tms_r@net.bio.net willl come to your email address
and also any message you send to 7tms_r@net.bio.net will also come to
your address.

Best wishes, also look at GCRDbWWW on the World Wide Web
http://receptor.mgh.harvard.edu/GCRDBHOME.html

Frank Kolakowski

Email: lfk@receptor.mgh.harvard.edu
617-735-7515 (LAB)
<A HREF="http://receptor.mgh.harvard.edu/GCRDBHOME.html">GCRDb-WWW</A>



From owner-7tms_r@net.bio.net Thu Mar 16 22:00:00 1995
Path: biosci!sb.com!Jonathan_A_Lee%notes
From: Jonathan_A_Lee%notes@sb.com (Jonathan A Lee)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Associate Scientist Position Opening
Date: 17 Mar 1995 09:47:00 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 43
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9503172046.AA5699@pho018.sb.com>
NNTP-Posting-Host: net.bio.net

Dear 7TM Netters,

I hope this is an appropriate use of the net.  My apologies if I am out of line.

I am seeking a motivated scientist to join an ongoing multidisciplinary effort 
to investigate the structure and ligand interactions of bioactive peptide 
receptors.

Requirements include a BS and MS in biochemistry, pharmacology or a related 
field.  Experience in receptor characterization (ligand binding and signal 
transduction assays) and familiarity with data analysis programs is preferred.  
Additional experience in molecular biology (subcloning, mutagenesis, PCR, 
sequencing, and gene expression) and the operation of laboratory robots is 
desirable. 

Examples of recent work from the laboratory can be found in the following 
references.

Lee, J.A., Elliott, Sutiphong, J.A, Friesen, W.J., Ohlstein, E.H. Stadel, J.M., 
Gleason, J.G., and Peishoff, C. E. (1994) "Tyrosine 129 Is Important to the 
Peptide Affinity and Selectivity of Human Endothelin A Receptor" Proc. Natl. 
Acad. Sci.  USA 91, 7164-7168.

Lee, J.A., Sutiphong, J.A., Longton, E.D.,  Peishoff, C. E., Stadel, J.M., 
Kumar, C., Ohlstein, E.H., Gleason, J.D., and Elliott, J.D  (1994) "Lysine 182 
of the Endothelin B Receptor is Important for Agonist Selectivity and 
Antagonist Affinity: Evidence for the Overlap of Peptide and Non-peptide Ligand 
Binding Sites" Biochemistry  33, 14543-14549.

For consideration, please contact Dr. Jonathan Lee.


Jonathan A. Lee
SmithKline Beecham Pharmaceuticals
Dept. Macromolecular Science
Mail COde UE 0447
709 Swedeland Road
King of Prussia, PA  19406

TEL: 610-270-7588
FAX: 610-270-4091
Email: Jonathan A Lee%notes@ab.com


From owner-7tms_r@net.bio.net Sun Mar 19 22:00:00 1995
Path: biosci!daresbury!not-for-mail
From: mcroos@imb-jena.de (Martin Roos)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Blotting of membrane receptors
Date: 20 Mar 1995 15:25:12 -0000
Lines: 31
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <3kk6oo$8fn@mserv1.dl.ac.uk>
Original-To: 7tms_r@dl.ac.uk

Dear netters,

my actual lab problem:
How can I increase the semi-dry transfer of a membran receptor (here:
endothelin-receptor) from SDS-PAGE to PVDF membranes?

 I am currently using a continous CAPS-buffered system, and I played around
with the SDS and MeOH content on the cathodic site of the blot sandwich, but
the results were not very convincing.
Any suggestions for the right proportion of SDS/MeOH?
Any suggestion for another blot system (acidic) ?

I will be happy about any comment.

Ciao, Martin



______________________________________________________________________________
Martin Roos..................................  e-mail: mcroos@imb-jena.de
Institut f|r Molekulare Biotechnologie e.V...  fax: ++49-3641-656431
Proteinlabor ................................  tel: ++49-3641-656263
Beutenbergstr. 11..........................................................
D-07745 Jena...............................................................
Germany
_______________________________________________________________________________
 





From owner-7tms_r@net.bio.net Sun Mar 19 22:00:00 1995
Path: biosci!sb.com!Jonathan_A_Lee%notes
From: Jonathan_A_Lee%notes@sb.com (Jonathan A Lee)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Associate Scientist Position Opening
Date: 20 Mar 1995 07:55:10 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 18
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9503201855.AA6337@pho018.sb.com>
NNTP-Posting-Host: net.bio.net

Dear 7TM Netters,

I had a typographical error on my message concerning the Associate Scientist 
position at SmithKline Beecham.

My E MAil address is :  

Jonathan A. Lee
SmithKline Beecham Pharmaceuticals
Dept. Macromolecular Science
Mail COde UE 0447
709 Swedeland Road
King of Prussia, PA  19406

TEL: 610-270-7588
FAX: 610-270-4091
Email: Jonathan A Lee%notes@sb.com (NOT ab.com)


From owner-7tms_r@net.bio.net Mon Mar 20 22:00:00 1995
Path: biosci!rutgers!uwm.edu!cs.utexas.edu!news.sprintlink.net!pipex!sunic!sunic.sunet.se!news.funet.fi!news.csc.fi!news.helsinki.fi!kruuna!paakkone
From: paakkone@cc.Helsinki.FI (Kimmo Paakkonen)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: subscribe
Date: 17 Mar 1995 13:11:53 GMT
Organization: University of Helsinki
Lines: 1
Message-ID: <3kc1qp$a88@oravannahka.Helsinki.FI>
NNTP-Posting-Host: kruuna.helsinki.fi
Mime-Version: 1.0
Content-Type: text/plain; charset=ISO-8859-1
Content-Transfer-Encoding: 8bit
X-Newsreader: TIN [version 1.2 PL0]

subscribe

From owner-7tms_r@net.bio.net Thu Mar 23 22:00:00 1995
Path: biosci!rutgers!uwm.edu!vixen.cso.uiuc.edu!howland.reston.ans.net!cs.utexas.edu!convex!news.duke.edu!news-feed-1.peachnet.edu!insosf1.infonet.net!newshost.marcam.com!zip.eecs.umich.edu!newsxfer.itd.umich.edu!news.itd.umich.edu!usenet
From: Rick Neubig <RNeubig@umich.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Mol Pharm Gordon Conference
Date: 24 Mar 1995 21:12:23 GMT
Organization: University of Michigan
Lines: 13
Message-ID: <3kvcjn$gb8@lastactionhero.rs.itd.umich.edu>
NNTP-Posting-Host: warbler.med.umich.edu

Hi 7tms_r's,

Things have been pretty quiet here so I'll try to start 
something.

Did anyone go to the Molecular Pharmacology Gordon Conference
in California in late February? I wanted to go but couldn't.

Any exciting new developments? Any word on x'tal structure of
G protein beta subunits?

Rick Neubig
http://www.umich.edu/~rneubig

From owner-7tms_r@net.bio.net Sun Mar 26 23:00:00 1995
Path: biosci!MIRIS.MED.YALE.EDU!mike
From: mike@MIRIS.MED.YALE.EDU ("Michael Singer")
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Record-breaking loops?
Date: 27 Mar 1995 13:53:35 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 6
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9503271656.ZM19321@miris.med.yale.edu>
NNTP-Posting-Host: net.bio.net

Can anyone name some GPCRs with especially large 2nd extracellular loops (the
loops between TM4 and TM5)?  How many residues?
Thanks,
Michael Singer
Yale School of Medicine


From owner-7tms_r@net.bio.net Mon Mar 27 23:00:00 1995
Path: biosci!WH.BAYER.COM!hyw
From: hyw@WH.BAYER.COM
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re:  Re; endocytosis poison
Date: 28 Mar 1995 07:29:28 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 99
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9503281522.AA13288@mrcs1>
NNTP-Posting-Host: net.bio.net






























q
























































q
q
q











From owner-7tms_r@net.bio.net Tue Mar 28 23:00:00 1995
Path: biosci!VAX.BIO.LEEDS.AC.UK!BMB6HDD
From: BMB6HDD@VAX.BIO.LEEDS.AC.UK
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: incomplete removal of radio-labelled agonist by unlabelled agonist?
Date: 29 Mar 1995 08:31:51 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 35
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <26E101BA_000DF7E0.0098E1832746FFF3$27_1@UK.AC.LEEDS.BIO.VAX>
NNTP-Posting-Host: net.bio.net


Greetings,

I wonder if anyone can help to answer a question.

     The human NK2 receptor:

     This receptor has approx. nM affinity for its natural peptide and for
     the non-peptide antagonist SR48,968. If the radio-ligand is 125I-NKA,
     then the IC50 for unlabelled NKA and SR48,968 is approx nM. In a decoupled
     system, the IC50 for the NKA drops to the uM range. If the radiolabelled
     ligand is 3H-SR48,968, then the IC50 for unlabelled SR48,968 is nM,
     but that for NKA is uM. The latter two IC50 values are unaltered in the
     decoupled system. Okay, so this can be explained by the ternary model -
     that is that 125I-NKA highlights a population of "active conformation" 
     coupled-receptors which have a high affinity for both NKA and SR48,968.
     If a decoupled system is imposed, the affinity of NKA drops but that
     of SR48,968 is unaltered. However, if 3H-SR48,968 is used as the 
     radio-ligand then a population of predominantly "inactive conformation" 
     decoupled-receptors is highlighted. NKA binds poorly to this state and
     decoupling conditions have little effect.

     What I don't understand is the following. When 3H-SR48,968 is used as the
     radio-ligand, unlabelled NKA can only remove about 70% of the counts
     compared to unlabelled SR48,968. Why?
 

See  "Rosenkilde et al. (1994) J. Biol. Chem. 269, 28160-28164" for the data.


Thanks in advance,

Dan Donnelly 
Dept Biochem + Mol Biol, University of Leeds, Leeds LS2 9JT, UK.
bmb6hdd@biovax.leeds.ac.uk

From owner-7tms_r@net.bio.net Tue Mar 28 23:00:00 1995
Path: biosci!VAX.BIO.LEEDS.AC.UK!BMB6HDD
From: BMB6HDD@VAX.BIO.LEEDS.AC.UK
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: incomplete removal of radio-labelled ANTagonist by unlabelled agonist?
Date: 29 Mar 1995 08:32:27 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 35
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <26E101BA_000DF390.0098E1833A014FB3$27_2@UK.AC.LEEDS.BIO.VAX>
NNTP-Posting-Host: net.bio.net


Greetings,

I wonder if anyone can help to answer a question.

     The human NK2 receptor:

     This receptor has approx. nM affinity for its natural peptide and for
     the non-peptide antagonist SR48,968. If the radio-ligand is 125I-NKA,
     then the IC50 for unlabelled NKA and SR48,968 is approx nM. In a decoupled
     system, the IC50 for the NKA drops to the uM range. If the radiolabelled
     ligand is 3H-SR48,968, then the IC50 for unlabelled SR48,968 is nM,
     but that for NKA is uM. The latter two IC50 values are unaltered in the
     decoupled system. Okay, so this can be explained by the ternary model -
     that is that 125I-NKA highlights a population of "active conformation" 
     coupled-receptors which have a high affinity for both NKA and SR48,968.
     If a decoupled system is imposed, the affinity of NKA drops but that
     of SR48,968 is unaltered. However, if 3H-SR48,968 is used as the 
     radio-ligand then a population of predominantly "inactive conformation" 
     decoupled-receptors is highlighted. NKA binds poorly to this state and
     decoupling conditions have little effect.

     What I don't understand is the following. When 3H-SR48,968 is used as the
     radio-ligand, unlabelled NKA can only remove about 70% of the counts
     compared to unlabelled SR48,968. Why?
 

See  "Rosenkilde et al. (1994) J. Biol. Chem. 269, 28160-28164" for the data.


Thanks in advance,

Dan Donnelly 
Dept Biochem + Mol Biol, University of Leeds, Leeds LS2 9JT, UK.
bmb6hdd@biovax.leeds.ac.uk

From owner-7tms_r@net.bio.net Tue Mar 28 23:00:00 1995
Path: biosci!daresbury!trane.uninett.no!Norway.EU.net!EU.net!howland.reston.ans.net!news2.near.net!das-news2.harvard.edu!oitnews.harvard.edu!bloch.nmr.mgh.harvard.edu!nntp.mgh.harvard.edu!lfk
From: lfk@receptor.mgh.harvard.edu (Lee F. (Frank) Kolakowski)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: JBC TOC Realted to 7tms_r (3/24-4/7)
Date: 29 Mar 1995 12:57:57 GMT
Organization: Mass. General Hospital, Renal Unit
Lines: 147
Distribution: world
Message-ID: <LFK.95Mar29075757@receptor.receptor.mgh.harvard.edu>
NNTP-Posting-Host: receptor.mgh.harvard.edu



AU Raychowdhury-M-K.  Yukawa-M.  Collins-L-J.  McGrail-S-H.  Kent-K-C.
   Ware-J-A.
TI Alternative splicing produces a divergent cytoplasmic tail in the human
   endothelial thromboxane A2 receptor. Vol. 269 (1994) 19256-19261.
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 7011.

AU Yakovlev-A-G.  Krueger-K-E.  Faden-A-I.
TI Structure and expression of a rat {kappa} opioid receptor gene
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6421.

AU Justice-J-M.  Bliziotes-M-M.  Stevens-L-A.  Moss-J.  Vaughan-M.
TI Involvement of N-myristoylation in monoclonal antibody recognition
   sites on chimeric G protein {alpha} subunits
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6436.

AU Kojro-E.  Fahrenholz-F.
TI Ligand-induced cleavage of the V2 vasopressin receptor by a plasma
   membrane metalloproteinase
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6476.

AU Parker-E-M.  Swigart-P.  Nunnally-M-H.  Perkins-J-P.  Ross-E-M.
TI Carboxyl-terminal domains in the avian {beta}1-adrenergic receptor that
   regulate agonist-promoted endocytosis
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6482.

AU Wang-J.  Ross-E-M.
TI The carboxyl-terminal anchorage domain of the turkey {beta}1-adrenergic
   receptor is encoded by an alternatively spliced exon
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6488.

AU Gardella-T-J.  Luck-M-D.  Wilson-A-K.  Keutmann-H-T.  Nussbaum-S-R.
   Potts-J-T-Jr..  Kronenberg-H-M.
TI Parathyroid hormone (PTH)-PTH-related peptide hybrid peptides reveal
   functional interactions between the 1-14 and 15-34 domains of the ligand
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6584.

AU Zhang-J.  Zhang-J.  Benovic-J-L.  Sugai-M.  Wetzker-R.  Gout-I.
   Rittenhouse-S-E.
TI Sequestration of a G-protein {beta}{gamma} subunit or ADP-ribosylation
   of Rho can inhibit thrombin-induced activation of platelet
   phosphoinositide 3-kinases
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6589.

AU Fukuda-K.  Kato-S.  Mori-K.
TI Location of regions of the opioid receptor involved in selective
   agonist binding
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6702.

AU Greene-N-M.  Williams-D-S.  Newton-A-C.
TI Kinetics and localization of the phosphorylation of rhodopsin by
   protein kinase C
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6710.

AU Morrison-D-F.  Ting-T-D.  Vallury-V.  Ho-Y-K.  Crouch-R-K.
   Corson-D-W.  Mangini-N-J.  Pepperberg-D-R.
TI Reduced light-dependent phosphorylation of an analog visual pigment
   containing 9-demethylretinal as its chromophore
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6718.

AU Ryba-N-J-P.  Tirindelli-R.
TI A novel GTP-binding protein {gamma}-subunit, G{gamma}8, is expressed
   during neurogenesis in the olfactory and vomeronasal neuroepithelia
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6757.

AU Seckl-M-J.  Morii-N.  Narumiya-S.  Rozengurt-E.
TI Guanosine 5{prime}-3-O-(thio)triphosphate stimulates tyrosine
   phosphorylation of p125FAK and paxillin in permeabilized Swiss 3T3
   cells. Role of p21rho.
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6984.

AU Iwasaki-S.  Homma-T.  Matsuda-Y.  Kon-V.
TI Endothelin receptor subtype B mediates autoinduction of endothelin-1 in
   rat mesangial cells
SO J-Biol-Chem.  1995 Mar 24.  270(12).  p 6997.

AU Clark-K-J.  Murray-A-W.
TI Evidence that the bradykinin-induced activation of phospholipase D and
   of the mitogen-activated protein kinase cascade involve different
   protein kinase C isoforms
SO J-Biol-Chem.  1995 Mar 31.  270(13).  p 7097.

AU Rousell-J.  Haddad-E-B.  Mak-J-C-W.  Barnes-P-J.
TI Transcriptional down-regulation of m2 muscarinic receptor gene
   expression in human embryonic lung (HEL 299) cells by protein kinase C
SO J-Biol-Chem.  1995 Mar 31.  270(13).  p 7213.

AU Guiramand-J.  Montmayeur-J-P.  Ceraline-J.  Bhatia-M.  Borrelli-E.
TI Alternative splicing of the dopamine D2 receptor directs specificity of
   coupling to G-proteins
SO J-Biol-Chem.  1995 Mar 31.  270(13).  p 7354.

AU Hogger-P.  Shockley-M-S.  Lameh-J.  Sadee-W.
TI Activating and inactivating mutations in N- and C-terminal i3 loop
   junctions of muscarinic acetylcholine Hm1 receptors
SO J-Biol-Chem.  1995 Mar 31.  270(13).  p 7405.

AU Pian-M-S.  Dobbs-L-G.
TI Evidence for G{beta}{gamma}-mediated cross-talk in primary cultures of
   lung alveolar cells. Pertussis toxin-sensitive production of cAMP.
SO J-Biol-Chem.  1995 Mar 31.  270(13).  p 7427.

AU Chaikof-E-L.  Caban-R.  Yan-C-N.  Rao-G-N.  Runge-M-S.
TI Growth-related responses in arterial smooth muscle cells are arrested
   by thrombin receptor antisense sequences
SO J-Biol-Chem.  1995 Mar 31.  270(13).  p 7431.

AU Buggy-J-J.  Livingston-J-N.  Rabin-D-U.  Yoo-Warren-H.
TI Glucagonglucagon-like peptide I receptor chimeras reveal domains that
   determine specificity of glucagon binding
SO J-Biol-Chem.  1995 Mar 31.  270(13).  p 7474.

AU Levin-L-R.  Reed-R-R.
TI Identification of functional domains of adenylyl cyclase using in vivo
   chimeras
SO J-Biol-Chem.  1995 Mar 31.  270(13).  p 7573.

AU Pan-Z.  Kravchenko-V-V.  Ye-R-D.
TI Platelet-activating factor stimulates transcription of the
   heparin-binding epidermal growth factor-like growth factor in
   monocytes. Correlation with an increased {kappa}B binding activity.
SO J-Biol-Chem.  1995 April 7.  270(14).  p 7787.

AU Jeohn-G-H.  Takahashi-K.
TI Purification and characterization of a vasoactive intestinal
   polypeptide-degrading endoprotease from porcine antral mucosal membranes
SO J-Biol-Chem.  1995 April 7.  270(14).  p 7809.

AU Kroog-G-S.  Sainz-E.  Worland-P-J.  Akeson-M-A.  Benya-R-V.
   Jensen-R-T.  Battey-J-F.
TI The gastrin-releasing peptide receptor is rapidly phosphorylated by a
   kinase other than protein kinase C after exposure to agonist
SO J-Biol-Chem.  1995 April 7.  270(14).  p 8217.

AU Vouret-Craviari-V.  Grall-D.  Chambard-J-C.  Rasmussen-U-B.
   Pouyssegur-J.  Obberghen-Schilling-E-V.
TI Post-translational and activation-dependent modifications of the G
   protein-coupled thrombin receptor
SO J-Biol-Chem.  1995 April 7.  270(14).  p 8367.
-- 
Frank Kolakowski

Email: lfk@receptor.mgh.harvard.edu
617-355-7515 (LAB)
<A HREF="http://receptor.mgh.harvard.edu/GCRDBHOME.html">GCRDb-WWW</A>


From owner-7tms_r@net.bio.net Tue Mar 28 23:00:00 1995
Path: biosci!daresbury!trane.uninett.no!Norway.EU.net!EU.net!Germany.EU.net!zib-berlin.de!cs.tu-berlin.de!fauern!winx03!wrzx15!phak004
From: phak004@wrzx15.rz.uni-wuerzburg.de (Cornelius Krasel)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Mol Pharm Gordon Conference
Date: 28 Mar 1995 19:08:24 GMT
Organization: University of Wuerzburg, Germany
Lines: 16
Message-ID: <3l9mr8$ee6@winx03.informatik.uni-wuerzburg.de>
References: <3kvcjn$gb8@lastactionhero.rs.itd.umich.edu>
NNTP-Posting-Host: wrzx15.rz.uni-wuerzburg.de
X-Newsreader: TIN [version 1.2 PL2]

Rick Neubig (RNeubig@umich.edu) wrote:
> Any exciting new developments? Any word on x'tal structure of
> G protein beta subunits?

Is there something like this to be expected? (If not, I always wondered
how complicated it would be to determine the structure of a single WD40
repeat by NMR?)

--Cornelius.

PS: Note changed location and email address :-)

--
/* Cornelius Krasel, Institut f. Pharmakologie, Versbacher Str. 9, D-97078 */
/* Wuerzburg, Germany                email: phak004@rzbox.uni-wuerzburg.de */
/* "Science is the game you play with God to find out what His rules are." */

From owner-7tms_r@net.bio.net Tue Mar 28 23:00:00 1995
Path: biosci!VAX.BIO.LEEDS.AC.UK!BMB6HDD
From: BMB6HDD@VAX.BIO.LEEDS.AC.UK
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: "locked R* receptors" / constitutively active receptors???????
Date: 29 Mar 1995 08:34:04 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 23
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <26E101BA_000DF7E0.0098E183748AF7D3$28_1@UK.AC.LEEDS.BIO.VAX>
NNTP-Posting-Host: net.bio.net


Another question:

Constitutively active receptors - i.e. receptors that can activate G 
proteins without agonist.

Such receptors have been widely reported. (1) Is this phenomenon a result of
over-expression so that the R<-->R* equilibrium is unaltered but there is
more R*, hence more basal activity. Or is it that the equilibrium is actually
shifted towards R* in an analogous manner to the presence of agonist.

R* is usually stabilized by the binding of both agonist and G protein.
If constitutively active receptors only require the G protein, then
(2) is it possible that a receptor can exist that only requires agonist
to stabilize R*? This would mean that high affinity agonist binding could
be obtained without G protein - useful in systems that have no appropriate/
insufficient amounts  of G protein.  The experiment to show this is relatively
simple but I was wondering whether this phenomenon has already been shown.


Dan Donnelly 
Dept Biochem + Mol Biol, University of Leeds, Leeds LS2 9JT, UK.
bmb6hdd@biovax.leeds.ac.uk

From owner-7tms_r@net.bio.net Wed Mar 29 23:00:00 1995
Path: biosci!rutgers!uwm.edu!msunews!gmi!srvr1.flint.umich.edu!newsxfer.itd.umich.edu!news.itd.umich.edu!usenet
From: Rick Neubig <RNeubig@umich.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re:
Date: 30 Mar 1995 15:15:54 GMT
Organization: University of Michigan
Lines: 86
Message-ID: <3lehva$rm8@lastactionhero.rs.itd.umich.edu>
References: <26E101BA_000DF7E0.0098E183748AF7D3$28_1@UK.AC.LEEDS.BIO.VAX>
NNTP-Posting-Host: warbler.med.umich.edu

BMB6HDD@VAX.BIO.LEEDS.AC.UK wrote:

> Constitutively active receptors - i.e. receptors that can activate G 
> proteins without agonist.
> 
> Such receptors have been widely reported. (1) Is this phenomenon a result of
> over-expression so that the R<-->R* equilibrium is unaltered but there is
> more R*, hence more basal activity. Or is it that the equilibrium is actually
> shifted towards R* in an analogous manner to the presence of agonist.

Both phenomena have been pretty clearly demonstrated. If you increase
expression levels of wild type (e.g. beta receptor in recent Nature article)
you can get increased basal activation of G protein and downstream effector.
The newer information relates to mutations in receptors (e.g. adrenergic
from Lefkowitz's lab plus rhotopsin in retinitis pigmentosa and the 
LH and TSH receptor mutations in humans. In these cases you get more
basal activation of effector at the same or even lower receptor
densities. This clearly shows that the receptors either have a greater
amount of R* or the R* is different and has a greater Vmax for activating
G protein. The former is the simpler hypothesis and so far seems
adequate to explain the data.

> 
> R* is usually stabilized by the binding of both agonist and G protein.
> If constitutively active receptors only require the G protein, then
> (2) is it possible that a receptor can exist that only requires agonist
> to stabilize R*? This would mean that high affinity agonist binding could
> be obtained without G protein - useful in systems that have no appropriate/
> insufficient amounts  of G protein.  The experiment to show this is relatively
> simple but I was wondering whether this phenomenon has already been shown.

A little recognized implication of early data on BARK is that agonist
can change the conformation of receptor to some state (either an
R' or the activated R* state). Agonist can stimulate BARK phosphorylation
of purified beta receptors without G protein being present. This means
that the activating conformational change does not require but is
enhanced by G protein as you mentioned. Similarly, the meta II state
of rhodopsin is induced by light but it is enhanced by the presence
of transducin.

If you wanted to use high affinity agonist binding to detect the
high affinity state of receptor with no G protein present you would
have difficulty. In the absence of a limiting amount of G protein 
(or some fraction of receptor which is unable to couple to G protein) 
the receptor would show a single apparent affinity even if some 
fraction is in the "high affinity" state. This is described in a
number of papers but two from my lab are:

Neubig, R. R., R. D. Gantzos, and R. S. Brasier. 1985. 
Agonist and antagonist binding to a2-adrenergic receptors 
in purified membranes from human platelets: 
implications of receptor-inhibitory nucleotide binding 
protein stoichiometry. 
Mol. Pharmacol 28:475-486.

Neubig, R. R. 1994. Membrane organization in G protein mechanisms. 
FASEB J 8:939-946.


Finally, it is interesting to me that so many people are surprised
about the idea that receptors can activate effectors in the
absence of agonist. Coming from the nicotinic acetylcholine
receptor field, I think it is well recognized that receptors can
be both spontaneously activated 

Jackson, M. B. 1984. Spontaneous openings of the acetylcholine 
receptor channel. Proc. Natl. Acad. Sci. U. S. A. 81:3901-3904.

and spontaneously desensitized

Boyd, N. D. and J. B. Cohen. 1980. Kinetics of binding of 
[3H]acetylcholine and [3H]carbamylcholine to Torpedo postsynaptic 
membranes: slow conformational changes of the cholinergic receptor. 
Biochemistry 19:5344-5353.


Also several groups (including mine) have provided evidence for
pre-coupling of 7tms_r's to G proteins without agonist and for
spontaneous activation without agonist (e.g. Costa for opiate
receptors).

The new information is most exciting in my view in the potential that
these mutations have as a cause of human disease. 

Rick Neubig
http://www.umich.edu/~rneubig

From owner-7tms_r@net.bio.net Thu Mar 30 23:00:00 1995
Path: biosci!daresbury!trane.uninett.no!sunic!sunic.sunet.se!seunet!news2.swip.net!doc.news.pipex.net!pipex!lyra.csx.cam.ac.uk!mole.bio.cam.ac.uk!flh
From: flh@mole.bio.cam.ac.uk (Frances Hannan (Zoology))
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: pM ligands for GPCRs
Date: 31 Mar 1995 14:58:03 GMT
Organization: University of Cambridge, England
Lines: 12
Message-ID: <3lh59r$r2a@lyra.csx.cam.ac.uk>
NNTP-Posting-Host: mole.bio.cam.ac.uk

Hi all,

Are there any cases of ligands which activate their receptors in the
picomolar range ie around 10-12? I have heard that some peptides act 
at 10-10. This sort of thing is difficult to extract using literature
searches so thanks for any help you can give...
 
-- 
Frances Hannan                                       
BILMS, Zoology, Downing St, Cambridge, CB2 3EJ, UK   
Phone (0223)336663, FAX (0223)461954                 
flh@mole.bio.cam.ac.uk                               

